Literature DB >> 25898994

Questionnaire surveillance of hidradenitis suppurativa in Japan.

Ichiro Kurokawa1, Nobukazu Hayashi2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25898994     DOI： 10.1111/1346-8138.12881

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  14 in total

1.  Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa.

Authors:  Joon Min Jung; Keon Hee Lee; Ye-Jee Kim; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Chong Hyun Won; Woo Jin Lee
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

Review 2.  Botulinum toxin type A for the management of hidradenitis suppurativa.

Authors:  Huanhuan Qu; Lin Gao
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 3.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

4.  Hidradenitis Suppurativa: An Asian Perspective from a Singaporean Institute.

Authors:  Ellie Choi; Alex R Cook; Nisha Suyien Chandran
Journal:  Skin Appendage Disord       Date:  2018-01-26

5.  Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages.

Authors:  Carmelo Carmona-Rivera; Liam J O'Neil; Eduardo Patino-Martinez; William D Shipman; Chengsong Zhu; Quan-Zhen Li; Michelle L Kerns; Leandra A Barnes; Julie A Caffrey; Sewon Kang; Mariana J Kaplan; Ginette A Okoye; Angel S Byrd
Journal:  J Invest Dermatol       Date:  2021-10-01       Impact factor: 8.551

6.  A Novel NCSTN Gene Mutation in a Japanese Family with Hidradenitis Suppurativa.

Authors:  Nobuyuki Nishimori; Koremasa Hayama; Kumiko Kimura; Hideki Fujita; Kyoko Fujiwara; Tadashi Terui
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875

7.  Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.

Authors:  Akimichi Morita; Hidetoshi Takahashi; Kentaro Ozawa; Shinichi Imafuku; Takekuni Nakama; Kenzo Takahashi; Takashi Matsuyama; Yukari Okubo; Susumu Kitamura; Naoto Matsuda; Yiwei Zhao; Masayuki Yokoyama; Nobukazu Hayashi; Tadashi Terui
Journal:  J Dermatol       Date:  2019-07-08       Impact factor: 4.005

8.  Earwax of patients with hidradenitis suppurativa: A retrospective study.

Authors:  Yuka Shibuya; Daichi Morioka; Misako Nomura; Zhuo Zhang; Hiroki Utsunomiya
Journal:  Arch Plast Surg       Date:  2019-11-15

9.  Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.

Authors:  Koremasa Hayama; Hideki Fujita; Takashi Hashimoto; Tadashi Terui
Journal:  J Dermatol       Date:  2020-05-22       Impact factor: 4.005

10.  Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.

Authors:  Natalia Kirsten; Nicole Zander; Matthias Augustin
Journal:  Arch Dermatol Res       Date:  2020-04-22       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.